KMLE
»çÀÌÆ® ¼Ò°³
°Ë»ö
°Ë»ö¾î Áö¿ì±â
´Ý±â
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
°í±Þ °Ë»ö ¼³Á¤
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
14
ÆäÀÌÁö:
11
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
Ŭ·ÎÀÚ¸±Á¤25mg
Clozapine 25 mg
Çѱ¹³ë¹ÙƼ½º
Àü¹®|±Þ¿©
311¿ø/1 °³
Ŭ¸®¹Ù¸°ÁÖ2863IU
Reviparin Sodium 27.12 mg
Çѱ¹¾Öº¸Æ®
Àü¹®|±Þ¿©
3723¿ø/0.5 °³
Ŭ¸®¹Ù¸°ÁÖ3436IU
Reviparin Sodium 32.54 mg
Çѱ¹¾Öº¸Æ®
Àü¹®|±Þ¿©
5451¿ø/0.6 °³
Ŭ¸®¹Ù¸°ÁÖ5153IU
Reviparin Sodium 48.82 mg
Çѱ¹¾Öº¸Æ®
Àü¹®|±Þ¿©
7103¿ø/0.9 °³
Ŭ¸®º¥ÀÚÁ¤
Cyclobenzaprine HCl 10 mg
¾ÆÀ̺ñÁø
Àü¹®|»èÁ¦
0¿ø/1 °³
Ŭ·¹ÄÜĸ½¶
Simethicone 200 mg, Clebopride Malate 0.68 mg
¾È±¹¾àǰ
Àü¹®|»èÁ¦
0¿ø/1 °³
Ŭ·ÎÁøÁ¤
Prochlorperazine Malate 8 mg
Çѱ¹À¯´Ï¿ÂÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/1 °³
Ŭ¶ó·Î¸¶°ÇÁ¶½Ã·´
Clarithromycin 25 mg/mL
°í·ÁÁ¦¾à
Àü¹®|±Þ¿©
142¿ø/1 °³
Ŭ¶ó·Î¸¶Á¤500mg
Clarithromycin 500 mg
°í·ÁÁ¦¾à
Àü¹®|±Þ¿©
1931¿ø/1 °³
Ŭ¸®´Ï¹Í½º85ÁÖ»ç2000mL
L-Leucine 6.20 , L-Phenylalanine 4.76 , L-Methionine 3.40 , Lysine HCl...
¹Ú½ºÅÍ
Àü¹®|±Þ¿©
34710¿ø/2 °³
Ŭ·¡½ÅÁ¤
Clarithromycin 250 mg
´ë¿øÁ¦¾à
Àü¹®|±Þ¿©
1289¿ø/1 °³
Ŭ¸®µåÁ¡¾È¾×
Potassium Iodide 3 mg/mL, Sodium Iodide 3 mg/mL
»ïõ´çÁ¦¾à
Àü¹®|±Þ¿©
142¿ø/1 °³
Ŭ¶ó¸ñ½ºÁ¤625mg
Potassium Clavulanate 125 mg, Amoxicillin Sodium 500 mg
¾ÆÁÖ¾àǰ°ø¾÷
Àü¹®|»èÁ¦
0¿ø/1 °³
Ŭ¶ó¸ñ½Åµà¿À½Ã·´
Amoxicillin Sodium 40 mg/mL, Potassium Clavulanate 5.7 mg/mL
Çѱ¹À¯´Ï¿ÂÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/1 °³
ÀÌÀü
´ÙÀ½
Sponsored Links
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
klystron
Ŭ¶óÀ̽ºÆ®·Ð
knuckle
Áß¼öÁö °üÀý, ¼öÁö °üÀý(â¢ò¦Î¼ï½), Áö °üÀý(ò¦Î¼ï½), Áß¼öÁöÀý °üÀý(ñéâ¢ò¦ï½Î¼ï½), Áö°ü Àý¹è¸é, ³ÊŬ.
knuckle pad
Áö°üÀý ÈÄ¹æ °áÀý(ò¦Î¼ï½ýÛ°Ì¿ï½), Áö°üÀý ¹æ¼®(ò¦Î¼ï½Û°à¬), ³ÊŬ ÆÐµå, Áö°üÀý¹è°áÀýÁõ.
massive myoclonus
¹Ì¿ÀŬ·Î´©½º´ë¹ßÀÛ(¡ÓÞÛ¡íÂ).
maximal clearance
ÃÖ´ëŬ¸®¾î·±½º, ±Ø<ÃÖ>´ëû¼Ò¿ëÀû(п<õÌ>
maximum urea clearance
ÃÖ°í¿ä¼Ò(õÌÍÔèñáÈ)Ŭ¸®¾î·±½º.
mental hygiene clinic
Á¤½ÅÀ§»ýŬ¸®´Ð.
metabolic clearance rate =MCR
´ë»çŬ¸®¾î·±½ºÀ².
midsystolic click
¼öÃàÁß±â(â¥õêñéÑ¢)Ŭ¸¯.
midsystolic click syndrome
¼öÃàÁß±â Ŭ¸¯Å© ÁõÈıº(â¥õêñéÑ¢ ¡ ñøý¦ÏØ)
mikulicz cells
¹ÌŬ¸®Ã÷ ¼¼Æ÷, Mikulicz ¼¼Æ÷(¡ á¬øà)
mikulicz syndrome
¹ÌŬ¸®Ã÷ ÁõÈıº, Mikulicz ÁõÈıº(¡ ñøý¦ÏØ)
mitigated ether
¿ÏÈ(èÐûú)¿¡Å׸£ ¡ìŬ·Î·ÎÆ÷¸§È¥ÇÕ¡í.
monochlormethane
¸ð³ëŬ·Î·Î¸Þź.
monochloroacetic acid
¸ð³ëŬ·Î·Î ¾Æ¼¼Æ®»ê.
ÀÌÀü
´ÙÀ½
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
2
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
UV endonuclease
UV ¿£µµ´©Å¬·¹À̽º
UVR+ endonuclease
UVR+ ¿£µµ´©Å¬·¹À̽ºV
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
11
ÄÚµå
¿µ¹®
ÇѱÛ
V25
Motorcycle rider injured in collision with railway train or railway vehicle
¿Â÷ ¶Ç´Â öµµÂ÷·®°ú Ãæµ¹·Î ´ÙÄ£ ¸ðÅÍ»çÀÌŬ ž½ÂÀÚ
V25.2
Unspecified motorcycle rider injured in nontraffic accident
ºñ±³Åë »ç°í¿¡¼ ´ÙÄ£ »ó¼¼ºÒ¸íÀÇ ¸ðÅͽÎÀÌŬ ž½ÂÀÚ
V25.9
Unspecified motorcycle rider injured in traffic accident
±³Åë»ç°í¿¡¼ ´ÙÄ£ »ó¼¼ºÒ¸íÀÇ ¸ðÅͽÎÀÌŬ ž½ÂÀÚ
V26
Motorcycle rider injured in collision with other nonmotor vehicle
±âŸ ¹«µ¿·ÂÂ÷·®°ú Ãæµ¹·Î ´ÙÄ£ ¸ðÅÍ»çÀÌŬ ž½ÂÀÚ
V26.2
Unspecified motorcycle rider injured in nontraffic accident
ºñ±³Åë »ç°í¿¡¼ ´ÙÄ£ »ó¼¼ºÒ¸íÀÇ ¸ðÅͽÎÀÌŬ ž½ÂÀÚ
ÀÌÀü
´ÙÀ½
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
10
ÆäÀÌÁö:
11
Ŭ·ÎÅ»Á¤
A42900301
ÆÇ¸Å»ç: À¯ÇѸ޵ðÄ«
¼ººÐ/ÇÔ·®: Aceclofenac
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ¶ô½Å°ÇÁ¶½Ã·´
A12955871
ÆÇ¸Å»ç: Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à
¼ººÐ/ÇÔ·®: Clarithromycin
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ¶óºÎƾÁ¤
A45950351
ÆÇ¸Å»ç: °æº¸¾àǰ
¼ººÐ/ÇÔ·®: Amoxicillin, Potassium clavulanate
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ·Î´Ð½ºÁ¤125mg
A13851261
ÆÇ¸Å»ç: ¾¾Æ®¸®
¼ººÐ/ÇÔ·®: Clonixin Lysinate
±¸ºÐ/º¸Çè±Þ¿©: ÀϹÝÀǾàǰ | »èÁ¦
Ŭ·¡¸¶À̽ŰÇÁ¶½Ã·´125mg/5ml
A20753661
ÆÇ¸Å»ç: ½ÅÀÏÁ¦¾à
¼ººÐ/ÇÔ·®: Clarithromycin
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ¶ó¸®½º°ÇÁ¶½Ã·´125mg/5ml
A03851421
ÆÇ¸Å»ç: °ÇÀÏÁ¦¾à
¼ººÐ/ÇÔ·®: Clarithromycin
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ¸®ÇÁĸ½¶
A27852281
ÆÇ¸Å»ç: ±¸ÁÖÁ¦¾à
¼ººÐ/ÇÔ·®: Cefaclor
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ¶óºÎƾ°ÇÁ¶½Ã·´
A45950471
ÆÇ¸Å»ç: °æº¸¾àǰ
¼ººÐ/ÇÔ·®: Amoxicillin, Potassium clavulanate
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ¶óºÎƾµà¿À°ÇÁ¶½Ã·´
A45950461
ÆÇ¸Å»ç: °æº¸¾àǰ
¼ººÐ/ÇÔ·®: Amoxicillin, Potassium clavulanate
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ¶ó¸®µåÁ¤
A03505151
ÆÇ¸Å»ç: ÇÑ¿ÃÁ¦¾à
¼ººÐ/ÇÔ·®: Clarithromycin
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
cleek
Ŭ¸®Å©(öÁ¦ °ñÇÁäÀÇ 1¹ø,¶§·Î´Â ¸ñÁ¦ °ñÇÁäÀÇ 4¹ø);°¥°í¶ûÀÌ
clematis
Ŭ·¹¸¶Æ¼½º(À¸¾Æ¼ÓÀÇ ½Ä¹°)
clementine
Ŭ·¹¸àŸÀÎ(tangerin°ú sour orangeÀÇ ÀâÁ¾ÀÎ ¼ÒÇü ¿À·»Áö)
clerihew
Ŭ·¹¸®ÈÞ(Àι°À» dzÀÚÇÏ´Â Àͻ콺·¯¿î ³»¿ëÀÇ »çÇà ¿¬±¸ÀÇ ÀÏÁ¾)
click stop
Ŭ¸¯ ½ºÅé(Ä«¸Þ¶ó µî¿¡¼ ÀÏÁ¤ÇÑ ´«±Ý¸¶´Ù µüÇÏ°í ¼Ò¸®³»¸ç ¸ØÃß´Â ÀåÄ¡)
client
(º¯È£»ç µîÀÇ)ÀÇ·ÚÀÎ;(»óÀÎÀÇ)°í°´;´Ü°ñ;Ŭ¶óÀ̾ðÆ®(º¹Áö »ç¾÷°¡ µîÀÇ µµ¿òÀ» ¹Þ´Â »ç¶÷);(·Î¸¶ ±ÍÁ·ÀÇ)¿¹¼Ó Æò¹Î;ºÎÇÏ;(°´ë±¹ÀÇ)Á¾¼Ó±¹;~less
climax
Ŭ¶óÀ̹齺;Á¡Ãþ¹ý;(»ç°Ç.±Ø µîÀÇ)ÃÖ°íÁ¶;ÀýÁ¤;ÃÖ°íÁ¡;±ØÁ¡;(¼ºÀûÀÎ)¿¢½ºÅͽÃ;¼ºÀû Äè°¨ÀÇ ÀýÁ¤;¿À¸£°¡½¿;±Ø»ó(½Ä¹° ±º¶ôÀÇ ¾ÈÁ¤±â);Ŭ¶óÀ̸ƽº¿¡ ´ÞÇÏ(°Ô ÇÏ)´Ù
clinch
(¹ÚÀº ¸øµîÀÇ ³¡À»)²¿ºÎ¸®´Ù;ÁË´Ù;°íÁ¤½ÃŰ´Ù;(»ç°Ç.Åä·Ð µîÀÇ)°á¸»À» Áþ´Ù;¹æºÙÀâ°í ½Î¿ì´Ù;¿òÄÑÁã°í ½Î¿ì´Ù;Ŭ¸°Ä¡ÇÏ´Ù;Æ÷¿ËÇÏ´Ù;¹åÁÙ ³¡À» ²¿ºÎ·Á µ¿¿©¹è´Ù;=CLENCH;(±ÇÅõ µî¿¡¼)²¸¾È´Ù;Ŭ¸°Ä¡ÇÏ´Ù;¿·ÄÈ÷ Æ÷¿ËÇÏ´Ù;¸ø³¡À» ²¿ºÎ¸®±â;(²¿ºÎ·Á) Á˱â;²¿ºÎ¸°¸ø(³ª»ç);(±ÇÅõ
clindamycin
Ŭ¸°´Ù¸¶À̽Å
cline
Ŭ¶óÀÎ;(Áö¿ªÀû)¿¬¼Ó º¯ÀÌ;Ŭ¶óÀÎ;¿¬¼Óº¯ÀÌ;¿¬¼Óü(continuum)
clinic
(º´¿ø.Àǰú´ëÇÐ ºÎ¼ÓÀÇ)Áø·á¼Ò;°³ÀÎ(Àü¹®)º´¿ø;Ŭ¸®´Ð;(º´¿ø³»ÀÇ)°ú;Ŭ¸®´ÐÀÇ ÀÇ»çµé;»ó´ã¼Ò;(¾î¶² ƯÁ¤ ¸ñÀûÀ¸·Î ¼³¸³µÈ)±³Á¤¼Ò;(ÀÇÇÐÀÇ)ÀÓ»ó°ÀÇ(ÀÇ Å¬·¡½º);(ÀÇÇÐ ÀÌ¿ÜÀÇ)½ÇÁö °ÁÂ;¼¼¹Ì³ª;=CLINICAL
clinker
¶¯±×¶ûÇÏ°í ¼Ò¸®³ª´Â °Í;¼ö°©;½Ç¼ö;À߸ø;(À½¾Ç¿¡¼)°¡¶ôÀÌ ¸ÂÁö ¾Ê´Â À½;½ÇÆÐÀÛ;1µîǰ;ÀÏǰ;¸Úµé¾îÁø »ç¶÷(°Í);Çü¹«¼Ò;Ŭ¸µÄ¿;¿ëÀ籫(¿ë±¤·Î ¼Ó¿¡ »ý±â´Â);(³×´ú¶õµå½ÄÀ¸·Î ±¸¿î)´Ü´ÜÇÑ º®µ¹;ÅõÈ º®µ¹;Ŭ¸µÄ¿·Î ¸¸µé´Ù(µÇ´Ù)
clinometer
Ŭ¸®³ë¹ÌÅÍ;°æ»ç°è
clip
²¸¾È´Ù;(Àå½Å±¸ µîÀÌ)Ŭ¸³À¸·Î °íÁ¤µÇ´Ù;(¸Ó¸®ÅÐ.¾çÅÐ µîÀ»)±ðÀ½;(ÇÑ ¹ø ¶Ç´Â ÇÑ Ã¶¿¡ ±ðÀº)¾çÅÐÀÇ ºÐ·®;¼Óµµ;ºü¸¥ °ÉÀ½;Àçºü¸¥ µ¿ÀÛ;°Å¸;ÇÑ ¹ø;ÇÑ ¹øÀÇ ³ë·Â;(¼·ùµîÀ» ³¢¿ì´Â ±Ý¼ÓÁ¦ µîÀÇ)Ŭ¸³;Á¾ÀÌ(¼·ù)Áý°Ô(³¢¿ì°³);(¸Ó¸®ÅÐÀ» °íÁ¤½ÃŰ´Â)Ŭ¸³;(¸¸³âÇÊ µîÀÇ)³¢¿ò¼è;Ŭ
clip joint
¹Ù°¡Áö¸¦ ¾º¿ì´Â ¾ûÅ͸® ¼úÁý(³ªÀÌÆ®Å¬·´.»óÁ¡µî)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
11
ÀÌÀü
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½